Literature DB >> 33713231

Prototype of a DNA Vaccine against Marburg Virus.

N V Volkova1, O V Pyankov2, A V Ivanova2, A A Isaeva2, A V Zybkina2, E I Kazachinskaya2, D N Shcherbakov2.   

Abstract

The preparation and study of the biological properties of the pVAKS-GPVM DNA immunogen containing a gene encoding Marburgvirus glycoprotein are described. The specificity of blood serum antibodies of guinea pigs immunized with DNA immunogen was analyzed by ELISA. Inactivated viral preparation, recombinant glycoprotein (GP) obtained in the prokaryotic system and virus-like particles based on the recombinant vesicular stomatitis virus exhibiting Marburgvirus GP were used as the antigens. The neutralizing activity of antibodies of immunized animals was tested in vitro using a pseudovirus system. It was demonstrated that the developed immunogen administered to guinea pigs induced the production of specific antibodies that neutralize virus-like particles and Marburgvirus in cultured Vero cells.

Entities:  

Keywords:  DNA immunogen; DNA vaccines; Marburg virus (MARV); Marburg virus glycoprotein

Year:  2021        PMID: 33713231     DOI: 10.1007/s10517-021-05091-w

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  Mechanism of human antibody-mediated neutralization of Marburg virus.

Authors:  Andrew I Flyak; Philipp A Ilinykh; Charles D Murin; Tania Garron; Xiaoli Shen; Marnie L Fusco; Takao Hashiguchi; Zachary A Bornholdt; James C Slaughter; Gopal Sapparapu; Curtis Klages; Thomas G Ksiazek; Andrew B Ward; Erica Ollmann Saphire; Alexander Bukreyev; James E Crowe
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

2.  [A comparative study of the immunological indices in guinea pigs administered an inactivated Marburg virus].

Authors:  G M Ignat'ev; A P Agafonov; M A Strel'tsova; V A Kuz'min; G I Maĭnagasheva; G V Spirin; N B Chernyĭ
Journal:  Vopr Virusol       Date:  1991 Sep-Oct

Review 3.  Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.

Authors:  John J Suschak; Connie S Schmaljohn
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.